Search Results - Farberg AS
- Showing 1 - 14 results of 14
-
1
-
2
-
3
Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorit... by Singh G, Tolkachjov SN, Farberg AS
Published in Clinical, Cosmetic and Investigational Dermatology (2023-04-01)Get full text
Article -
4
-
5
-
6
-
7
Inconsistent Associations Between Risk Factor Profiles and Adjuvant Radiation Therapy (ART) Treatment in Patients with Cutaneous Squamous Cell Carcinoma and Utility of the 40-Gene... by Brent R. Moody, Aaron S. Farberg, Ally-Khan Somani, Walton A. Taylor
Published in Dermatology and Therapy (2024-03-01)Get full text
Article -
8
Commercial Diagnostics and Emerging Precision Medicine Technologies in Psoriasis and Atopic Dermatitis by Haran K, Kranyak A, Johnson CE, Smith P, Farberg AS, Bhutani T, Liao W
Published in Psoriasis: Targets and Therapy (2024-08-01)Get full text
Article -
9
-
10
The State of the Art of Image Guided Superficial Radiation Therapy Treatment of Non-melanoma Skin Cancer in Outpatient Dermatology Clinics in the United States and Review of the Li... by Peyton M. Harris, Aaron S. Farberg, Janine Hopkins, Liqiao Ma, Donna Serure, Blake Robbins, Candace Osborne, Luis Bravo, Pauline Lausser, Amanda Boatner
Published in Oncology and Therapy (2024-11-01)Get full text
Article -
11
Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients by Sherri Borman, Jeff Wilkinson, Lauren Meldi-Sholl, Clare Johnson, Kelsey Carter, Kyle R. Covington, Alison L. Fitzgerald, Sarah J. Kurley, Aaron S. Farberg, Matthew S. Goldberg, Federico A. Monzon, Kristen Oelschlager, Robert W. Cook
Published in Diagnostic Pathology (2022-02-01)Get full text
Article -
12
Improving systemic therapy selection for inflammatory skin diseases: A clinical need surveyCapsule Summary by Nicholas D. Brownstone, MD, Aaron S. Farberg, MD, Graham H. Litchman, DO, MS, Ann P. Quick, PhD, Jennifer J. Siegel, PhD, Lenka V. Hurton, PhD, Matthew S. Goldberg, MD, Peter A. Lio, MD
Published in JAAD International (2024-09-01)Get full text
Article -
13
Sonidegib reduced tumor burden in patients with advanced basal cell carcinoma in the BOLT trial: Long-term analysis results by Michael R. Migden, Aaron S. Farberg, James Spencer, Felix Kiecker, Alexander Guminski, Kurt Gebauer, Carmen Loquai, Caroline Robert, Reinhard Dummer, Dirk Schadendorf, Axel Hauschild, Jean Jacques Grob, Nicholas Squittieri, Ramon Arntz, Serena Martelli, Joerg Dierlamm, Ralf Gutzmer
Published in EJC Skin Cancer (2024-12-01)Get full text
Article -
14
Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma... by Ashley Wysong, Ally‐Khan Somani, Sherrif F. Ibrahim, Javier Cañueto, Alison L. Fitzgerald, Jennifer J. Siegel, Anesh Prasai, Matthew S. Goldberg, Aaron S. Farberg, Christie Regula, Anna Bar, Julia Kasprzak, David G. Brodland, Shlomo A. Koyfman, Sarah T. Arron
Published in Dermatology and Therapy (2024-03-01)Get full text
Article
